Synthesis of novel N'-(2-oxoindolin-3-ylidene)benzofuran-2-carbohydrazides via greener approach and their biological activities

Der Pharma Chemica

Volumn 6, Issue 1, 2014, Pages 272-278

  Bhardwaj, Bharti ^a   Jain, Subhash C ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

Aqueous medium; Benzo b furan; Condensation reaction; Hydrazones; Indoline 2,3 diones

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BENZOFURAN 2 CARBOXYLIC ACID HYDRAZIDE; BENZOFURAN DERIVATIVE; ETHYLBENZOFURAN 2 CARBOXYLATE; N' (1 METHYL 2 OXOINDOLIN 3 YLIDENE)BENZOFURAN 2 CARBOHYDRAZIDE; N' (2 OXOINDOLIN 3 YLIDENE)BENZOFURAN 2 CARBOHYDRAZIDE; N' (2 OXOINDOLIN 3 YLIDENE)BENZOFURAN 2 CARBOHYDRAZIDE DERIVATIVE; N' (5 BROMO 1 METHYL 2 OXOINDOLIN 3 YLIDENE)BENZOFURAN; N' (5 BROMO 1 METHYL 2 OXOINDOLIN 3 YLIDENE)BENZOFURAN 2 CARBOHYDRAZIDE; N' (5 BROMO 2 OXOINDOLIN 3 YLIDENE)BENZOFURAN 2 CARBOHYDRAZIDE; N' (5 CHLORO 1 METHYL 2 OXOINDOLIN 3 YLIDENE)BENZOFURAN 2 CARBOHYDRAZIDE; N' (5 CHLORO 2 OXOINDOLIN 3 YLIDENE)BENZOFURAN 2 CARBOHYDRAZIDE; N' (5 FLUORO 1 METHYL 2 OXOINDOLIN 3 YLIDENE)BENZOFURAN 2 CARBOHYDRAZIDE; N' (5 FLUORO 2 OXOINDOLIN 3 YLIDENE)BENZOFURAN 2 CARBOHYDRAZIDE; N' (5 METHYL 2 OXOINDOLIN 3 YLIDENE)BENZOFURAN 2 CARBOHYDRAZIDE; N' (5 NITRO 2 OXOINDOLIN 3 YLIDENE)BENZOFURAN 2 CARBOHYDRAZIDE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; BACILLUS SUBTILIS; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG FORMULATION; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; GREEN CHEMISTRY; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; NONHUMAN; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHI; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84903366584     PISSN: None     EISSN: 0975413X     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. S. Rollas, S.G. Kuchkguzel, Molecules, 2007, 12, 1910.
2. U. Salgm-Goksen, N. Gokhan-Kelekci, O. Goktas, Y. Koysal, E. Kilic, S. Isik, G. Aktay, M. Ozalp, Bioorg. Med. Chem., 2007, 15, 738
3. A C. L. Leite, R. S. de Lima, D. R. D., Moreira, V. D. O. Cardoso, A. C. G. de Brito,; L. M. F. dos Santos, M. Z. Hernandes,; A. C. Kiperstok, R. S. de Lima,; M. B. P. Soares, Bioorg. Med. Chem., 2006, 14, 3749
4. S Bondock, W. Khalifa, A. A. Fadda, Eur. J. Med. Chem., 2007, 42, 948.
5. For a review on imine, see: R. W. Layer, Chem. Rev. 1963, 63, 489.
6. J. H. Billman, K. M. Tai, J. Org. Chem., 1958, 23, 535.
7. H. Weingart, J. P. Chupp, W. A. White, J. Org. Chem., 1967, 32,213.
8. R. S. Vaas, J. Dudas, R. S. Varma, Tetrahedron Lett., 1999, 40, 4951.
9. S. M. Landge, V. Atanassova, M. Thimmaih, B. Torok, Tetrahedron Lett., 2007, 48, 5161.
10. B. P. Branchaud, J. Org. Chem., 1983, 48, 3531.
11. A. K. Chakraborti, S. Bhagat, S. Rudrawar, Tetrahedron Lett., 2004,45, 7641.
12. A. Bazgir, J. Chem. Res., 2006, 1, 1.
13. Y. Yu, Asian J. Chem., 2007, 19, 2476.
14. K. P. Guzen,; A. S. Guarezemini, A. T. G. Orfaõ, R. Cella, C. M. P. Pereira, H. A. Stefani, Tetrahedron Lett., 2007, 48, 1845.
15. G. Aguirre, L. Boiani, H. Cerecetto, M. Fernandez, M. Gonzalez, A. Denicola, L. Otero, D. Gambino, C. Rigol, C. Olea-Azar, M. Faundez, Bioorg. Med. Chem. 2004, 12, 4885.;
16. H. Cerecetto, R. D. Maio, M. González, M. Risso, G. Sagrera, G. Seoane, A. Denicola, G. Pellufo, C. Quijano, A. O. M. Stoppanie, M. Paulino, C. Olea-Azarg,; M. G. Basombríoh, Eur. J. Med. Chem., 2000, 35, 343.
17. H. X. Jiang, Q. Liu, K.Gao, Natural Product Research., 2008, 22, 11937.
18. A. H. Banskota, Y. Tezuka, K. Midorikawa, K. Matsushige, S. Kadota, J. Nat. Prod., 2000, 63, 1277-1279
19. H. Ebiike, M. Masubuchi, P. Liu, K. Kawasaki, K. Morikami, S. Sogabe, M. Hayase, T. Fujii, K. Sakata, H. Shindoh, Y. Shiratori, Y. Aoki, T. Ohtsukaa, Shimma, N. Bioorg. Med. Chem. Lett., 2002, 12, 607.
20. D. M. X. Donelly, M. J. Meegan, In Comprehensive Heterocyclic Chemistry. A. R. Katritzky, Ed. (Pergamon, New York, 1984), vol. 4, p. 712.
21. P. Cagniant, D. Cagniant, Adv. Heterocycl. Chem., 1975, 18, 482.
22. C. W. Bird, G. W. H. Cheeseman, In Comprehensive Heterocyclic Chemistry, A. R. Katritzky, Ed. (Pergamon, New York, 1984), vol. 4, p. 153.
23. S. Lourdes, M. Teijeiraa, E. Uriartea, C. Teranb, B. Linãresc, R. Villar, R. Laguna, E. Cano, European Journal of Pharmaceutical Sciences, 1998, 7, 161.
24. M. W. Khan, M. J. Alam, M. A. Rashid, R. Chowdhury, Bioorg. Med. Chem., 2005, 13, 4796.
25. M. Masubuchi, K. Kawasaki, H. Ebiike, Y. Ikeda, S. Tsujii, S. Sogabe, T. Fujii, K. Sakata, Y. Shiratori, Y. Aoki, T. Ohtsukaa, N. Shimma, Bioorg. Med. Chem. Lett., 2001, 11, 1833.
26. S. K. Bhattacharya, S. K. Mitra, S. B. Acharya, J. Psychopharmacol., 1991, 5, 202.
27. S. K. Bhattacharya, S. Chakrabarti, Indian J. Exp. Biol., 1998, 36, 118.
28. S. K. Bhattacharya, V. Glover, I. McIntyre, G. Oxenkrug, M. Sandler, Neurosci. Lett., 1982, 92, 218.
29. V. Alagarsamy, S. Meena, R. Revathi, Indian J. Pharm. Sci , 2004, 4, 459.
30. V. Alagarsamy, K. V. Ramseshu, Pharmazie., 2003, 58, 233-36.
31. S. K. Sridhar, M. Sreenivasulu, Indian drugs., 2001, 38, 531-34.
32. S. N. Pandeya, D. Sriram, G. Nath, E. DeClercq, Eur. J. Pharm. Sci., 1999, 9, 25.
33. R. S. Verma, W. Nobles, J. Pharm. Sci., 1975, 69, 881.
34. V. H. Tran, Q. D. Nguyen, N. V. Le, Tap. Chi. Dou Hoc., 2002, 8, 15.
35. F. D. Popp, R. Parson, B. E. Donigan, J. Pharm. Sci., 1980, 69, 1235.
36. S. C. Jain, J. Sinha, S. Bhagat, W. Errington, C. E. Olsen, Syn. Comm., 2003, 33, 563.
37. S. Parekh, D. Bhavsar, M. Savan, S. Thakrar, A. Bavishi, M. Parmar, H. Vala, A. Radadiya, N. Pandya, J. Serly, J. Molnár, A. Shah, Eur. J. Med. Chem., 2011, 46 1942.
38. A. L. Barry In The Antimicrobic Susceptibility Test: Principles and Practices; Lea & Febiger: Philadelphia, 1976, p 180-194
39. P. M. Reddy, Y. P. Ho, K. Shanker, R. Rohini, V. Ravinder, Eur. J. Med. Chem., 2009, 44, 2621.